Peter Welford

Stock Analyst at Jefferies

(2.48)
# 2,307
Out of 4,896 analysts
13
Total ratings
80%
Success rate
8.29%
Average return

Stocks Rated by Peter Welford

GSK plc
Nov 12, 2024
Downgrades: Hold
Price Target: n/a
Current: $38.26
Upside: -
Novartis AG
Sep 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $121.25
Upside: -
AstraZeneca
Jan 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $71.07
Upside: -
Galapagos NV
Jan 23, 2023
Upgrades: Hold
Price Target: $49$47
Current: $30.36
Upside: +55.47%
Genmab
Sep 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $21.43
Upside: -